Harold E. Brakewood - 31 Mar 2023 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Chief Business Officer
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Harold E. Brakewood
Issuer symbol
IMRX
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Apr 2023, 16:54:52 UTC
Previous filing
03 Apr 2023
Next filing
09 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +165,000 $0.000000 165,000 31 Mar 2023 Class A Common Stock 165,000 $9.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on January 23, 2024 and then in equal monthly installments over the subsequent three years, subject to Mr. Brakewood's continued employment through each applicable vesting date.